InsidersTradesSigma
伟思医疗 Stock: price and directors' dealings · China · SSE / SZSE (CSRC)
Follow the 伟思医疗 stock price and the full directors' dealings record of the company, a listed equity based in China. Shares are quoted on CN CN, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 伟思医疗 has recorded 9 insider filings. Market capitalisation: €4.6bn. The latest transaction was reported on 5 January 2026 (Sale). Among the most active insiders: 高飞. Every trade is free.
9
Insider Decl.
0
Thresholds
·
2 ops.
Buy Volume
·
7 ops.
Sell Volume
18Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 8,722 of 26,213 companies
59.9
score / 100
Value36
Quality84
FCF yld1.1%
Earn yld2.7%
EV/EBITDA28.1x
ROE9.7%
Gross mgn66%
Net mgn30%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 5 January 2026
Declarations9 total
9 of 9 declarations